These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 51886)

  • 1. Anomalous reactions of mouse alloantisera with cultured tumor cells. I. Demonstration of widespread occurrence using reference typing sera.
    Klein PA
    J Immunol; 1975 Nov; 115(5):1254-60. PubMed ID: 51886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anomalous reactions of mouse alloantisera with cultured tumor cells. II. Cytotoxicity is caused by antibodies to leukemia viruses.
    Nowinski RC; Klein PA
    J Immunol; 1975 Nov; 115(5):1261-8. PubMed ID: 170342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of antigens on murine tumor cells reacting with alloantisera against foreign H-2 specificities: analysis by absorption with purified murine leukemia virus and normal lymphoid cells of different H-2 haplotypes.
    Schirrmacher V; Marxen I; Robinson P
    Z Immunitatsforsch Immunobiol; 1978 Dec; 155(2):155-68. PubMed ID: 85374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H-2/HLA cross-reactions. Absorption analysis of cytotoxic antihuman activity in anti-H-2 mouse sera.
    Iványl P; Pavijuková H; Ivasková E
    Transplantation; 1976 Dec; 22(6):612-8. PubMed ID: 795111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
    Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H
    Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of stimulation in murine mixed lymphocyte cultures with an alloantiserum directed against a shared Ia determinant.
    Schwartz RH; Fathman CG; Sachs DH
    J Immunol; 1976 Apr; 116(4):929-35. PubMed ID: 56405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ir-associated murine alloantigens: demonstration of multiple Ia specificities in H-2 alloantisera after selective absorptions.
    Sachs DH; Cone JL
    J Immunol; 1975 Jan; 114(1 Pt 1):165-9. PubMed ID: 122984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ia antigens in inbred rats and their relationship to the MLR phenotype.
    Radka SF; Cramer DV; Gill TJ
    J Immunol; 1977 Dec; 119(6):2037-44. PubMed ID: 144165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
    Sensi ML; Parenza M; Parmiani G
    J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A syngeneic anti tumor serum recognizing a complex H-2 alloantigen.
    Garrido F; Perez M; Torres MD; Garcia-Olivares E; Ivanyi P; Schirrmacher V
    Immunobiology; 1979 Aug; 156(1-2):110-20. PubMed ID: 540966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mouse-primed lymphocyte typing test. III. Dissociation of T lymphocyte-stimulating determinants and antibody-defined specificities of the I region-associated Ia antigens.
    Peck AB; Klein J; Wigzell H
    J Immunol; 1980 Sep; 125(3):1978-86. PubMed ID: 6157729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reacting antigens in chemically induced sarcomas are fetal determinants.
    Parker GA; Rosenberg SA
    J Immunol; 1977 May; 118(5):1590-4. PubMed ID: 67142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of SJL/J reticulum cell sarcoma tumor-associated Ia antigens by T cell hybridomas: characterization of tumor-specific and shared epitopes detected on IE+ allogeneic cells.
    Ohnishi K; Bonavida B
    J Immunol; 1986 Jul; 137(2):733-40. PubMed ID: 2424977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
    Gupta RK; Silver HK; Reisfeld RA; Morton DL
    Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sharing of Ia antigens between species. IV. Interspecies cross-reactivity of monoclonal antibodies directed against polymorphic mouse Ia determinants.
    Lunney JK; Osborne BA; Sharrow SO; Devaux C; Pierres M; Sachs DH
    J Immunol; 1983 Jun; 130(6):2786-93. PubMed ID: 6406596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of H-2 antigens of wild mice (Mus musculus L.).
    Micková M; Iványi P
    Folia Biol (Praha); 1976; 12(3):169-89. PubMed ID: 62682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloantisera reacting with tumor cells of inappropriate haplotype. I. Characterization of target antigens.
    Prat M; Rogers MJ; Appella E
    J Natl Cancer Inst; 1978 Aug; 61(2):527-34. PubMed ID: 79659
    [No Abstract]   [Full Text] [Related]  

  • 20. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.